Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.90
IVC's Cash to Debt is ranked lower than
64% of the 321 Companies
in the Global Medical Devices industry.

( Industry Median: 2.30 vs. IVC: 0.90 )
Ranked among companies with meaningful Cash to Debt only.
IVC' s 10-Year Cash to Debt Range
Min: 0  Med: 0.04 Max: 1.91
Current: 0.9
0
1.91
Equity to Asset 0.57
IVC's Equity to Asset is ranked lower than
59% of the 287 Companies
in the Global Medical Devices industry.

( Industry Median: 0.66 vs. IVC: 0.57 )
Ranked among companies with meaningful Equity to Asset only.
IVC' s 10-Year Equity to Asset Range
Min: 0.32  Med: 0.47 Max: 0.61
Current: 0.57
0.32
0.61
F-Score: 2
Z-Score: 3.06
M-Score: -2.88
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 3/10

vs
industry
vs
history
Operating margin (%) -3.79
IVC's Operating margin (%) is ranked lower than
59% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 3.12 vs. IVC: -3.79 )
Ranked among companies with meaningful Operating margin (%) only.
IVC' s 10-Year Operating margin (%) Range
Min: -4.78  Med: 6.10 Max: 10.8
Current: -3.79
-4.78
10.8
Net-margin (%) -3.60
IVC's Net-margin (%) is ranked lower than
58% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 1.45 vs. IVC: -3.60 )
Ranked among companies with meaningful Net-margin (%) only.
IVC' s 10-Year Net-margin (%) Range
Min: -21.21  Med: 2.84 Max: 6.39
Current: -3.6
-21.21
6.39
ROE (%) -7.60
IVC's ROE (%) is ranked lower than
62% of the 289 Companies
in the Global Medical Devices industry.

( Industry Median: 2.94 vs. IVC: -7.60 )
Ranked among companies with meaningful ROE (%) only.
IVC' s 10-Year ROE (%) Range
Min: -51.33  Med: 6.49 Max: 17.92
Current: -7.6
-51.33
17.92
ROA (%) -4.49
IVC's ROA (%) is ranked lower than
56% of the 324 Companies
in the Global Medical Devices industry.

( Industry Median: -0.62 vs. IVC: -4.49 )
Ranked among companies with meaningful ROA (%) only.
IVC' s 10-Year ROA (%) Range
Min: -20.26  Med: 2.98 Max: 8.47
Current: -4.49
-20.26
8.47
ROC (Joel Greenblatt) (%) -24.59
IVC's ROC (Joel Greenblatt) (%) is ranked lower than
60% of the 318 Companies
in the Global Medical Devices industry.

( Industry Median: 3.55 vs. IVC: -24.59 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
IVC' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -61.77  Med: 22.21 Max: 54.75
Current: -24.59
-61.77
54.75
Revenue Growth (3Y)(%) -5.30
IVC's Revenue Growth (3Y)(%) is ranked lower than
70% of the 193 Companies
in the Global Medical Devices industry.

( Industry Median: 3.20 vs. IVC: -5.30 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
IVC' s 10-Year Revenue Growth (3Y)(%) Range
Min: -5.5  Med: 6.00 Max: 17.3
Current: -5.3
-5.5
17.3
EPS Growth (3Y)(%) 54.80
IVC's EPS Growth (3Y)(%) is ranked higher than
92% of the 170 Companies
in the Global Medical Devices industry.

( Industry Median: -2.00 vs. IVC: 54.80 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
IVC' s 10-Year EPS Growth (3Y)(%) Range
Min: -74.2  Med: 8.40 Max: 239.1
Current: 54.8
-74.2
239.1
» IVC's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2014

IVC Guru Trades in Q2 2014

HOTCHKIS & WILEY 1,243,400 sh (New)
Chuck Royce 1,689,436 sh (+27.11%)
Paul Tudor Jones Sold Out
Jim Simons 87,000 sh (-64.30%)
» More
Q3 2014

IVC Guru Trades in Q3 2014

HOTCHKIS & WILEY 2,173,400 sh (+74.79%)
Jim Simons Sold Out
Chuck Royce 1,680,036 sh (-0.56%)
» More
Q4 2014

IVC Guru Trades in Q4 2014

Charles Brandes 65,985 sh (New)
HOTCHKIS & WILEY 2,162,700 sh (unchged)
HOTCHKIS & WILEY 2,162,700 sh (-0.49%)
Chuck Royce 1,535,742 sh (-8.59%)
» More
Q1 2015

IVC Guru Trades in Q1 2015

Joel Greenblatt 26,909 sh (New)
HOTCHKIS & WILEY 2,187,632 sh (+1.15%)
Chuck Royce 1,343,342 sh (-12.53%)
Charles Brandes 31,775 sh (-51.85%)
» More
» Details

Insider Trades

Latest Guru Trades with IVC

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 1.37
IVC's P/B is ranked higher than
83% of the 291 Companies
in the Global Medical Devices industry.

( Industry Median: 3.23 vs. IVC: 1.37 )
Ranked among companies with meaningful P/B only.
IVC' s 10-Year P/B Range
Min: 0.55  Med: 1.15 Max: 2.36
Current: 1.37
0.55
2.36
P/S 0.54
IVC's P/S is ranked higher than
92% of the 298 Companies
in the Global Medical Devices industry.

( Industry Median: 3.28 vs. IVC: 0.54 )
Ranked among companies with meaningful P/S only.
IVC' s 10-Year P/S Range
Min: 0.26  Med: 0.46 Max: 1.21
Current: 0.54
0.26
1.21
Shiller P/E 113.53
IVC's Shiller P/E is ranked lower than
86% of the 95 Companies
in the Global Medical Devices industry.

( Industry Median: 31.07 vs. IVC: 113.53 )
Ranked among companies with meaningful Shiller P/E only.
IVC' s 10-Year Shiller P/E Range
Min: 10.84  Med: 23.61 Max: 1227.5
Current: 113.53
10.84
1227.5
Current Ratio 1.38
IVC's Current Ratio is ranked lower than
81% of the 313 Companies
in the Global Medical Devices industry.

( Industry Median: 2.53 vs. IVC: 1.38 )
Ranked among companies with meaningful Current Ratio only.
IVC' s 10-Year Current Ratio Range
Min: 1.36  Med: 2.06 Max: 2.75
Current: 1.38
1.36
2.75
Quick Ratio 0.83
IVC's Quick Ratio is ranked lower than
84% of the 313 Companies
in the Global Medical Devices industry.

( Industry Median: 2.00 vs. IVC: 0.83 )
Ranked among companies with meaningful Quick Ratio only.
IVC' s 10-Year Quick Ratio Range
Min: 0.83  Med: 1.44 Max: 1.96
Current: 0.83
0.83
1.96
Days Inventory 63.82
IVC's Days Inventory is ranked higher than
85% of the 284 Companies
in the Global Medical Devices industry.

( Industry Median: 129.39 vs. IVC: 63.82 )
Ranked among companies with meaningful Days Inventory only.
IVC' s 10-Year Days Inventory Range
Min: 50.69  Med: 59.42 Max: 66.43
Current: 63.82
50.69
66.43
Days Sales Outstanding 47.45
IVC's Days Sales Outstanding is ranked higher than
80% of the 276 Companies
in the Global Medical Devices industry.

( Industry Median: 68.45 vs. IVC: 47.45 )
Ranked among companies with meaningful Days Sales Outstanding only.
IVC' s 10-Year Days Sales Outstanding Range
Min: 46.1  Med: 67.93 Max: 104.19
Current: 47.45
46.1
104.19

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.23
IVC's Dividend Yield is ranked lower than
95% of the 168 Companies
in the Global Medical Devices industry.

( Industry Median: 1.43 vs. IVC: 0.23 )
Ranked among companies with meaningful Dividend Yield only.
IVC' s 10-Year Dividend Yield Range
Min: 0.1  Med: 0.23 Max: 0.46
Current: 0.23
0.1
0.46
Yield on cost (5-Year) 0.23
IVC's Yield on cost (5-Year) is ranked lower than
94% of the 175 Companies
in the Global Medical Devices industry.

( Industry Median: 1.37 vs. IVC: 0.23 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
IVC' s 10-Year Yield on cost (5-Year) Range
Min: 0.1  Med: 0.23 Max: 0.46
Current: 0.23
0.1
0.46
Share Buyback Rate 0.20
IVC's Share Buyback Rate is ranked higher than
81% of the 183 Companies
in the Global Medical Devices industry.

( Industry Median: -3.70 vs. IVC: 0.20 )
Ranked among companies with meaningful Share Buyback Rate only.
IVC' s 10-Year Share Buyback Rate Range
Min: 1.3  Med: -0.20 Max: -1.2
Current: 0.2

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 7.92
IVC's Price/Tangible Book is ranked lower than
72% of the 262 Companies
in the Global Medical Devices industry.

( Industry Median: 4.56 vs. IVC: 7.92 )
Ranked among companies with meaningful Price/Tangible Book only.
IVC' s 10-Year Price/Tangible Book Range
Min: 3.31  Med: 8.59 Max: 94.61
Current: 7.92
3.31
94.61
Price/Projected FCF 0.73
IVC's Price/Projected FCF is ranked higher than
87% of the 112 Companies
in the Global Medical Devices industry.

( Industry Median: 1.95 vs. IVC: 0.73 )
Ranked among companies with meaningful Price/Projected FCF only.
IVC' s 10-Year Price/Projected FCF Range
Min: 0.33  Med: 0.77 Max: 3.85
Current: 0.73
0.33
3.85
Price/Median PS Value 1.17
IVC's Price/Median PS Value is ranked lower than
56% of the 264 Companies
in the Global Medical Devices industry.

( Industry Median: 1.16 vs. IVC: 1.17 )
Ranked among companies with meaningful Price/Median PS Value only.
IVC' s 10-Year Price/Median PS Value Range
Min: 0.6  Med: 1.66 Max: 3.42
Current: 1.17
0.6
3.42
Earnings Yield (Greenblatt) (%) -6.89
IVC's Earnings Yield (Greenblatt) (%) is ranked lower than
67% of the 316 Companies
in the Global Medical Devices industry.

( Industry Median: 0.20 vs. IVC: -6.89 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
IVC' s 10-Year Earnings Yield (Greenblatt) (%) Range
Min: -6.89  Med: 6.20 Max: 10.8
Current: -6.89
-6.89
10.8
Forward Rate of Return (Yacktman) (%) -23.27
IVC's Forward Rate of Return (Yacktman) (%) is ranked lower than
92% of the 98 Companies
in the Global Medical Devices industry.

( Industry Median: 4.08 vs. IVC: -23.27 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
IVC' s 10-Year Forward Rate of Return (Yacktman) (%) Range
Min: -19.1  Med: 8.30 Max: 20.4
Current: -23.27
-19.1
20.4

Business Description

Industry: Medical Devices » Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ » details
Traded in other countries:IV3.Germany,
Invacare Corp was incorporated in 1971. The Company manufactures and distributes in various markets for medical equipment used in the home and long-term care settings based upon its distribution channels, breadth of product line and net sales. It also designs, manufactures and distributes an extensive line of health care products for the non-acute care environment, including the home health care and extended care markets. The Company sells its products to home health care and medical equipment providers, distributors and government locations in the United States, Europe, Canada, New Zealand, Australia and Asia. Its products are sold through the distribution network by its sales force, telesales associates and independent manufacturers' representatives and distributors. The Company operates in four primary business segments; North America/Home Medical Equipment or North America/HME, Institutional Products Group (IPG), Europe and Asia/Pacific. The North America/HME segment sells each of three primary product lines, which includes; lifestyle, mobility and seating and respiratory therapy products. IPG sells or rents long-term care medical equipment, health care furnishings and accessory products. Europe and Asia/Pacific sell product lines similar to North America/HME and IPG. Each business segment sells to the home health care, retail and extended care markets. The Company purchases raw materials, fabricated components, some finished goods and services from a variety of suppliers. Raw materials such as plastics, steel and aluminum are considered key raw materials. The Company's North America/HME sales and marketing organization consists primarily of a sales force which markets and sells Invacare branded products to HME providers. It also holds patent and other intellectual property licenses from third parties for some of its products and on technologies that are necessary in the design and manufacture of some of the Company's products. The Company is directly affected by government regulation and reimbursement policies in virtually every country in which the Company operates.
» More Articles for IVC

Headlines

Articles On GuruFocus.com
Invacare Corporation: Sell First, Ask Questions Later? Feb 15 2012 
Invacare Corp. Reports Operating Results (10-K) Feb 25 2011 
Invacare Corp. Reports Operating Results (10-Q) Nov 05 2010 
Invacare Corp. Reports Operating Results (10-Q) Aug 06 2010 
Invacare Corp. Reports Operating Results (10-Q) May 06 2010 
Invacare Corp. Reports Operating Results (10-Q) Nov 05 2009 
Invacare Corp. Reports Operating Results (10-Q) May 07 2009 
Invacare Corporation Reports Earnings within Guidance and Strong Free Cash Flow Jan 29 2009 
Invacare Corporation to Host Conference Call to Discuss Q4 2008 Results Jan 20 2009 
Weekly CEO Buys Highlight: American Water Works Company, Inc., CocaCola Enterprises Inc., SAVVIS Inc May 07 2008 

More From Other Websites
Invacare Corporation Announces Sale of Invacare Rentals Jul 02 2015
Invacare Corporation Announces Sale of Invacare Rentals Jul 02 2015
What's China Doing About Stock Market Selloff? Not Much Jul 02 2015
Invacare Chairman and Chief Executive Officer Presenting at CJS Securities Summer Conference Jun 30 2015
Mal Mixon to Retire from Invacare Board of Directors Jun 19 2015
INVACARE CORP Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD... Jun 19 2015
Mal Mixon to Retire from Invacare Board of Directors Jun 19 2015
Considering the Investment Impact of Baby Boomers’ Retirement May 25 2015
Invacare Corporation to Present at Jefferies 2015 Global Healthcare Conference May 19 2015
INVACARE CORP Financials May 15 2015
INVACARE CORP Files SEC form 8-K, Change in Directors or Principal Officers May 15 2015
Invacare Corporation Adds Two New Board Members May 14 2015
Invacare Corporation Adds Two New Board Members May 14 2015
Invacare Declares Quarterly Dividend May 14 2015
Invacare Declares Quarterly Dividend May 14 2015
Buyout groups vie for wheelchair maker Sunrise Medical -sources May 13 2015
10-Q for Invacare Corp. May 08 2015
INVACARE CORP Files SEC form 10-Q, Quarterly Report May 06 2015
INVACARE CORP Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under... Apr 24 2015
Invacare Corporation Completes Sale and Leaseback Transaction Apr 23 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK